Interleukin-12 promotes recovery from viral encephalitis

Viral Immunology

Volumn 10, Issue 1, 1997, Pages 35-47

  Komatsu, Takashi ^a   Barna, Maria ^a   Reiss, Carol S ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE SYNTHASE; RECOMBINANT INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; SURVIVAL; VESICULAR STOMATITIS VIRUS; VIRUS ENCEPHALITIS; VIRUS TITRATION; WEIGHT REDUCTION;

EID: 0030928503     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1997.10.35     Document Type: Article

References (23)

1. Allavena, P., C. Paganin, D. Zhou., G. Bianchi, S. Sozzani, and A. Mantovani. 1994. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 84:2261-2268.
2. Barna, M., T. Komatsu, and C.S. Reiss. 1996. Activation of type lu nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology 223:331-343.
3. Bernardini, R., T.C. Kamilaris, A.E. Calogero, E.O. Johnson, M.T. Gomez, P.W. Gold, and G.P. Chrousos. 1990. Interactions between tumor necrosis factor-α, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology 126:2876-2881.
4. Besedovsky, H.O., A. Del. Rey, I. Klusman, H. Furukawa, G.M. Arditi, and A. Kabiersch. 1991. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol. 40:613-618.
5. Bi, Z., Barna, M., Komatsu, T., and Reiss, C.S. 1995a. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J. Virol. 69:6466-6472.
6. Bi, Z., Quandt, P., Komatsu, T., Barna, M., and Reiss, C.S. 1995b. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J. Immunol. 155:5684-5689.
7. Bi, Z., and C.S. Reiss. 1995. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:2208-2213.
8. Biron, C.A., K.S. Byron, and J.L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl. J. Med. 320:1731-1735.
9. Chan, S.H., B. Perussia, J.W. Gupta, M. Kobayashi, M. Pospisil, H.A. Young, S. Wolf, D. Young, S.C. Clark, and G. Trinchieri. 1991. Induction of interferon-γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-879.
10. Chehimi, A., N. Valiante, A. D'Andrea, M. Rengaraju, Z. Rosado, M. Kobayashi, B. Perussia, S.F. Wolf, S.E. Starr, and G. Trinchieri. 1993. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur. J. Immunol. 23:1826-1830.
11. Christian, A.Y., M. Barna, Z. Bi, and C.S. Reiss. 1996. Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BI/6 mice. Viral Immunol. 9:195-205.
12. Constantinescu, C.S., Frei, K., Malipiero, U., Rostami, A., and Fontana, A. 1996. Astrocytes and microglial produce IL-12. Ann. NY Acad. Sci. 795:328-333.
13. Coutelier, J.P., J.V. Broeck, and S.F. Wolf. 1995. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69:1955-1958.
14. Fischer, D.G., Tal, N., Novick, D., Barak, S., and Rubinstein, M. 1993. An antiviral soluble form of the LDL Receptor induced by interferon. Science 262:250-253.
15. Fong, Y., L.L. Moldawer, M. Marano, K. Manogue, K.J. Tracey, H. Wei, G. Kuo, D.A. Fischman, A. Cerami, and S.F. Lowry. 1989. Cachectin/TNF-α or IL-1 induces cachexia with redistribution of body proteins. Am. J. Physiol. 256:R659-R665.
16. Fong, Y., K.J. Tracey, L.L. Moldawer, D.G. Hesse, K.B. Manogue, J.S. Kenney, A.T. Lee, G.C. Juo, A.C. Allison, S.F. Lowry, and A. Cerami. 1989. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170:1627-1633.
17. d system. J. Virol. 65:4950-4958.
18. Gately, M.K., A.G. Wolitzky, P.M. Quinn, and R. Chizzonite. 1992. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol. 143:127-142.
19. Gazzinelli, R.T., M. Wysocka, S. Hayashi, E.Y. Denkers, S. Hieny, P. Casper, G. Trinchieri, and A. Sher. 1994a. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.
20. Gazzinelli, R.T., N.A. Giese, and H.C. Morse III. 1994b. In vivo treatment with interleukin-12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J. Exp. Med. 180:2199-2208.
21. Gruber, J., R. Sgonc, Y.H. Hu, H. Beug, and G. Wick. 1994. Thymocyte apoptosis induced by elevated andogenous corticosterone levels. Eur. J. Immunol. 24:1115-1121.
22. Harris, N., Buller, R.M., and Karupiah, G. 1995. Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69:910-915.
23. Heinzel, F.P., D.S. Shoenhaut, R.M. Rerko, L.E. Rosser, and M.K. Gately. 1993. Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.